{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:54:24Z","timestamp":1783727664973,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1012,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/ajt.15564","type":"journal-article","created":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T09:48:46Z","timestamp":1565430526000},"page":"593-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hyperacute graft dysfunction in an orthotopic heart transplant in the presence of non-HLA antibodies"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-0522","authenticated-orcid":false,"given":"Cecelia","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cristy Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre M.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Coletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Klohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.15564_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.healun.2018.01.1291","article-title":"The management of antibodies in heart transplantation: an ISHLT consensus document","volume":"37","author":"Kobashigawa","year":"2018","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15564_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management. A scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation."},{"key":"10.1111\/ajt.15564_bib3","first-page":"47","article-title":"Increased sensitization to HLA and to cardiac self-antigens (myosin and Vimentin) in patients waiting for cardiac transplantation with left ventricular assisting Device (LVAD) [Abstract]","volume":"S25","author":"Banan","year":"2014","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15564_bib4","first-page":"82","article-title":"Identification of non-HLA antibodies in ventricular assist device recipients","volume":"S46","author":"von Salisch","year":"2012","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15564_bib5","unstructured":"Hickey M, Reed E. Antibodies to angiotensin type II receptor I are associated with primary graft dysfunction after orthotopic heart transplant in patients with ventricular assist device as bridge to transplant. In: Proceedings from the 2017 American Transplant Congress; April 29\u2013May 3, 2017; Chicago, IL. Abstract 225."},{"key":"10.1111\/ajt.15564_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/icvts\/ivv344","article-title":"The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in heart mate II bridged recipients","volume":"22","author":"Urban","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"10.1111\/ajt.15564_bib7","doi-asserted-by":"crossref","first-page":"e13178","DOI":"10.1111\/ctr.13178","article-title":"Revealing a new mode of sensitization induced by mechanical circulatory support devices: impact of anti-AT1R antibodies","volume":"32","author":"Zhang","year":"2018","journal-title":"Clin Transplant."},{"issue":"9","key":"10.1111\/ajt.15564_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after Heart Transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15564_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies\u2019 on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15564_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-recetor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1111\/ajt.15564_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","article-title":"Angiotensin II-mediated microvascular thrombosis hypertension","volume":"56","author":"Senchenkova","year":"2010","journal-title":"Hypertension."},{"key":"10.1111\/ajt.15564_bib12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting angiotensin type 1 receptor and antibody mediated rejection. Clinic for Nephrology and Intensive Care Medicine, Campus Virchow-Klinikum and Center for Cardiovascular Research, Medical Facility of the Charite, Berlin Germany","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum Immunol."},{"key":"10.1111\/ajt.15564_bib13","doi-asserted-by":"crossref","first-page":"7903471","DOI":"10.1155\/2017\/7903471","article-title":"Not all antibodies are created equal: factors that influence antibody mediated rejection","volume":"2017","author":"Butler","year":"2017","journal-title":"J Immunol Res."},{"key":"10.1111\/ajt.15564_bib14","first-page":"434","article-title":"Impact of non-human leukocyte antigen-specific antibodies in kidney and heart transplantation","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol."},{"issue":"8","key":"10.1111\/ajt.15564_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneph.2016.88","article-title":"The importance of non-HLA antibodies in transplantation","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"10.1111\/ajt.15564_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.healun.2015.03.002","article-title":"Late antibody-mediated rejection after heart transplantation: mortality, graft function, and fulminant cardiac allograft vasculopathy","volume":"34","author":"Coutance","year":"2015","journal-title":"J Heart Lung Transplant."},{"issue":"5","key":"10.1111\/ajt.15564_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.healun.2016.10.016","article-title":"Donor specific anti-HLA antibodies with antibody mediated rejection and long-term outcomes following heart transplantation","volume":"36","author":"Clerkin","year":"2017","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15564_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15564_bib19","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretansplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15564_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/TP.0000000000001231","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies","volume":"101","author":"Philogene","year":"2017","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15564_bib21","first-page":"3","article-title":"Can\u2019t always blame anti-HLA antibody: angiotensin II type 1 receptor (AT1R) antibody and renal allograft vascular rejection","volume":"1","author":"Shamseddin","year":"2017","journal-title":"J Nephrol Urol."},{"key":"10.1111\/ajt.15564_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.humimm.2016.07.207","article-title":"P142 hyperacute rejection in a kidney transplant recipient with no HLA antibodies","volume":"77","author":"Lemp","year":"2016","journal-title":"Hum Immunol."},{"key":"10.1111\/ajt.15564_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.humimm.2017.06.276","article-title":"P216 Case of suspected hyperacute renal transplant rejection due to angiotensin II type 1 receptor antibodies","volume":"78","author":"Pohlmeyer","year":"2017","journal-title":"Hum Immunol."},{"issue":"6","key":"10.1111\/ajt.15564_bib24","first-page":"1643","article-title":"Multiple hyperacute rejection in the absence of detectable complement activation in a patient with endothelial cell reactive antibody","volume":"12","author":"Jackson","year":"2012","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15564_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ajt.14053","article-title":"Immediate and catastrophic antibody-mediated rejection in a lung transplant recipient with anti-angiotensin II receptor type I and anti-endothelin-1 receptor type A antibodies","volume":"17","author":"Cozzi","year":"2017","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15564_bib26","doi-asserted-by":"crossref","first-page":"e0134175","DOI":"10.1371\/journal.pone.0134175","article-title":"The role of angiotensin II and cyclic AMP in alveolar active sodium transport","volume":"10","author":"Ismael-Badarneh","year":"2015","journal-title":"PLoS ONE."},{"key":"10.1111\/ajt.15564_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature."},{"key":"10.1111\/ajt.15564_bib28","series-title":"KCENTRA\u00ae (Prothrombin Complex Concentrate (Human)) [package insert]","year":"2013"},{"issue":"5","key":"10.1111\/ajt.15564_bib29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15564","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15564","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15564","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522222138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522222138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:55Z","timestamp":1761629155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522222138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1600613522222138"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15564","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperacute graft dysfunction in an orthotopic heart transplant in the presence of non-HLA antibodies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}